Selecta Biosciences, Inc. (SELB) Social Stream



Selecta Biosciences, Inc. (SELB): $0.88

0.08 (-8.00%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add SELB to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#57 of 345

in industry

SELECTA BIOSCIENCES INC (SELB) Price Targets From Analysts

Use the tables below to see what analysts covering SELECTA BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-11 5 $10 $6 $8 $0.958 735.07%
2022-03-11 5 $10 $6 $7.75 $0.958 708.98%
2022-05-06 4 $10 $6 $7.25 $0.958 656.78%
2022-06-06 6 $10 $6 $7.2 $0.958 651.57%
2022-06-14 6 $7 $5 $6 $0.958 526.3%
2023-01-13 5 $7 $4 $5.5 $0.958 474.11%
2023-03-07 5 $9 $4 $6.2 $0.958 547.18%
2023-04-13 6 $9 $4 $6.166 $0.958 543.63%
2023-05-08 6 $5 $4 $4.666 $0.958 387.06%
2023-08-18 6 $5 $3 $4.5 $0.958 369.73%

The Trend in the Analyst Price Target


Over the past 52 weeks, SELB's average price target has gone down $1.

SELB reports an average of 314.87% for its upside potential over the past 35 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-13 6 7 4 5.500 1.69 225.44%
2023-04-05 6 9 4 6.166 1.30 374.31%
2023-05-05 6 9 4 5.833 1.08 440.09%
2023-05-08 6 5 4 4.666 1.19 292.1%
2023-08-18 6 5 3 4.500 1.13 298.23%

SELB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 4 1 1 0 0 6

The Trend in the Broker Recommendations


SELB's average broker recommendation rating improved by 0.25 over the prior 24 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • SELB has a greater average analyst price target than 100.88% of all US stocks.
  • SELB has a higher upside potential (average analyst target price relative to current price) than 1659.98% of all US stocks.
  • In the context of Healthcare stocks, SELECTA BIOSCIENCES INC's number of analysts covering the stock is higher than 566.84% of them.
  • In terms of how SELECTA BIOSCIENCES INC fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -1034.36% of that group.

In the Pharmaceutical Products industry, ACIU, SNDX, and NEPT are the three stocks most similar to SELECTA BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.

What is the outlook for SELB? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!